Skip to content
Stay updated with the latest UK poker news, expert tips, an…

Patients Coming Off Anti-Obesity Medications Put On Weight at a Quadrupled Rate Than Dieters

Image of medical syringe and weighing machine
Obesity treatment often requires ongoing approaches.

Fresh analysis indicates that people who discontinue popular slimming jabs like semaglutide or tirzepatide can put back on reduced body mass at a significantly accelerated pace than those who stop traditional diet and exercise programs.

Research printed in a major health publication points out that while obese people often shed substantial amounts of their body weight while undergoing treatment, the mass comes back at an average rate of nearly a kilo each month upon discontinuation.

"Individuals using these medications must be informed of the danger of fast rebound weight gain when the treatment is stopped," warns researcher Dr. Susan Jebb.

Such speed of recovery suggests a reversion to starting weight in about 18 months.

Weighing Approaches

The analysis, which reviewed dozens of trials involving thousands of participants, contrasted the outcomes of GLP-1 agonists with older methods.

Scientists emphasize that people who shed pounds through lifestyle changes alone generally see a more gradual weight regain—approximately 100 grams monthly—after stopping.

Explaining the Quick Rebound

Nutrition scientists propose the way of the drugs accounts for the accelerated weight return.

GLP-1 drugs copy a natural hormone called GLP-1, which helps regulate hunger.

"Artificially providing GLP-1 levels far above than normal might result in the body to produce less of its endogenous hormone, and could reduce sensitivity to its effects," explained Dr. Adam Collins, a nutrition specialist.

"Discontinuation of this medication results in hunger is no longer kept in check, making excessive eating a significant risk."

A Chronic Condition?

Medical guidelines suggest the injections for people with weight-linked medical conditions, accompanied by recommended lifestyle changes.

Professionals say that, given the high risk of weight regain, the therapy should be considered life-long.

This perspective is supported by pharmaceutical companies, who say that the findings "highlight the long-term nature of obesity," similar to managing conditions like hypertension.

User Experiences

People who have come off the medication report a powerful return of appetite.

"It felt as if a switch flipping and I was suddenly ravenous," recalled an individual.

This challenge is exacerbated if patients have not adopted permanent dietary or behavioural modifications during therapy.

Growing Interest

Recent estimates suggest that a significant number of people in the UK have used these injections in the past year, with demand continuing to grow.

  • Use is greater among women compared to males.
  • The middle-aged age group shows the highest usage rates.
  • Many access the medications through private healthcare rather than public health services.

Finally, experts caution that while these medications are powerful agents for shedding pounds, they are not a permanent fix and lasting health benefits relies on integrated lifestyle changes.

NW
Written by

Nicole Washington

Experienced poker journalist with 10+ years covering the UK poker scene.

Brit Poker Media

Type to search articles.